Michel Levesque, MD, Founder, Principal Investigator
Michel Lévesque,MD, is the Founder of Neurogeneration. A successful neuroscientist and neurosurgeon, Dr Levesque is also Director of the Los Angeles Neurosurgical Institute. He is an Associate Clinical Professor of Neurosurgery at the UCLA School of Medicine, member of the UCLA Brain Research Institute. He is the Chairman of the Foundation for Neural Repair, a not-for-profit foundation, sponsoring translational research to accelerate human trials using neural stem cells. Dr. Lévesque has authored over 75 articles in professional journals, contributed chapters to many leading neurosurgery treatises, has published over 200 scientific abstracts, and inventor of 7 patents. Dr. Lévesque received his medical degree at University of Montreal and completed post-graduate studies in neurosciences, studying central nervous system regeneration at Mc Gill University under Dr Albert Aguayo. He completed his neurosurgical training at the Montreal Neurological Institute and Mc Gill University, and a fellowship in functional neurosurgery.
Mohamedi Kagalwala, PhD, MBA, Chief Scientific Officer
Mohamedi “Mo” Kagalwala, PhD, MBA, is the chief scientific officer at Neurogeneration. Dr. Kagalwala is responsible for overseeing the research and development activities including discovery and pre-clinical studies with all assets in the pipeline. He is regarded as one of the pioneers in the field of chromatin and epigenetics for his contributions to chromatin remodeling. Dr. Kagalwala trained at Bhaba Atomic Research Center, Trombay, India and National Center for Biological Sciences, Bangalore, India. Dr. Kagalwala was then offered a Research Associate position in neurobiology and neurodegenerative disorders at the Salk Institute in La Jolla, CA under Prof. Fred “Rusty” Gage. There he expanded his knowledge and expertise of neural stem cells to understand adult neurogenesis in the hippocampus and carried out biochemical and functional genomic analysis of iPSC derived Neural Stem Cells from Schizophrenia patients. There he laid the solid foundation for the proposed research by understanding the molecular mechanisms of new neuron birth and maturation, mechanisms that are also apparent in aging and neurodegeneration.